Skip to Content

Tumor-Killing Nanoparticles

A new class of imaging particles seeks out cancers’ blood vessels.
March 1, 2007

A new class of nanoparticles that accumulate inside tumors could one day improve imaging quality and cancer treatment by delivering image-­enhancing agents or cancer drugs directly to tumor sites. A team led by Erkki Ruoslahti, a professor at the Burnham Institute for Medical Research in La Jolla, CA, coated iron oxide nanoparticles with a peptide that is attracted to protein clots in tumor blood vessels. When injected into mice with breast cancer, the nanoparticles sought out the tumors and bound to their blood-vessel walls. For reasons the researchers do not yet understand, the particles also induced more clotting, which attracted more particles, enhancing their effectiveness and potentially choking off a tumor’s lifeblood. The team is working to ensure that the particles won’t build up in normal tissues.

Fluorescent peptides attached to iron oxide particles glow bright green in a tumor (top left) and in the liver in these images of mice.

Keep Reading

Most Popular

A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?

Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.

A startup says it’s begun releasing particles into the atmosphere, in an effort to tweak the climate

Make Sunsets is already attempting to earn revenue for geoengineering, a move likely to provoke widespread criticism.

10 Breakthrough Technologies 2023

Every year, we pick the 10 technologies that matter the most right now. We look for advances that will have a big impact on our lives and break down why they matter.

These exclusive satellite images show that Saudi Arabia’s sci-fi megacity is well underway

Weirdly, any recent work on The Line doesn’t show up on Google Maps. But we got the images anyway.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.